As of June 18, 2025, Open Orphan PLC (ORPH.L) reports a Forward P/E of N/A.
Forward P/E gauges the price investors pay for each dollar of anticipated earnings, offering insight into a stock's future valuation.
Comparing Open Orphan PLC's Forward P/E to Peers
To better understand Open Orphan PLC's position, it's useful to compare its Forward P/E against industry peers. Below are selected comparisons:
| Company | Forward P/E |
|---|---|
| Open Orphan PLC (ORPH.L) | - |
| Diaceutics PLC (DXRX.L) | 5074.84 |
| Ergomed PLC (ERGO.L) | 2863.39 |
| Genovis AB (GENO.ST) | 57.21 |
| Selvita SA (SLV.WA) | 50.17 |
| AddLife AB (ALIF B.ST) | 49.36 |
Compared to its competitors, Open Orphan PLC's Forward P/E is difficult to compare due to insufficient data.